Clinical trial

GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer

NCT00320411

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-11-28

PhasePHASE2

Study timeline

Study start (unknown)2005-11-28Date precision: day

Registry last updated2019-01-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Neoplasms, Breastunresolved

Interventions

lapatinibDRUG · verified · RxNorm: lapatinib

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

TokyoJapan3 FukuokaJapan1 OkayamaJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00320411 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.